menopur
ferring gmbh - menotropinas - milteliai ir tirpiklis injekciniam tirpalui - 75 tv - human menopausal gonadotrophin
melatonin neurim
rad neurim pharmaceuticals eec sarl - melatoninas - miego inicijavimo ir priežiūros sutrikimai - psicholeptikai - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - netinkamas adh sindromas - diuretikai, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).
orserdu
stemline therapeutics b.v. - elacestrant - krūties navikai - endokrininė terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
floron 20 mg/g, vaistinis premiksas
krka d.d., novo mesto (slovėnija) - milteliai - zithromax zithromax 100 g vaistinio premikso yra: florfenikolio – 2 g. - kiaulėms ir žuvims, sergančioms infekcinėmis ligomis, kurių sukėlėjai jautrūs florfenikoliui, gydyti.
uniflox
unimed pharma spol. s r.o. - ofloksacinas - akių lašai (tirpalas) - 3 mg/ml - antiinfectives
polygynax
laboratoire innotech international - neomicino sulfatas/polimiksino b sulfatas/nistatinas - makšties minkštosios kapsulės - 35000 tv/35000 tv/100000 tv - nystatin, combinations
doxitin
vitabalans oy - doksiciklinas - tabletės - 150 mg; 100 mg - doxycycline